Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2017 Nov 9;11(11):CD011252.
doi: 10.1002/14651858.CD011252.pub2.

Medical and dietary interventions for preventing recurrent urinary stones in children

Adam Kern  1 , Gwen Grimsby, Helen Mayo, Linda A Baker
Affiliations

Medical and dietary interventions for preventing recurrent urinary stones in children

Adam Kern et al. Cochrane Database Syst Rev. .

Abstract

Background: Nephrolithiasis, or urinary stone disease, in children causes significant morbidity, and is increasing in prevalence in the North American population. Therefore, medical and dietary interventions (MDI) for recurrent urinary stones in children are poised to gain increasing importance in the clinical armamentarium.

Objectives: To assess the effects of medical and dietary interventions (MDI) for the prevention of idiopathic urinary stones in children aged from one to 18 years.

Search methods: We searched multiple databases using search terms relevant to this review, including studies identified from the Cochrane Central Register of Controlled Trials (CENTRAL, 2017, Issue 1), MEDLINE OvidSP (1946 to 14 February 2017), Embase OvidSP (1980 to 14 February 2017), International Clinical Trials Register (ICTRP) Search Portal and ClinicalTrials.gov. Additionally, we handsearched renal-related journals and the proceedings of major renal conferences, and reviewed weekly current awareness alerts for selected renal journals. The date of the last search was 14 February 2017. There were no language restrictions.

Selection criteria: Randomized controlled trials of at least one year of MDI versus control for prevention of recurrent idiopathic (non-syndromic) nephrolithiasis in children.

Data collection and analysis: We used standard methodologic procedures expected by Cochrane. Titles and abstracts were identified by search criteria and then screened for relevance, and then data extraction and risk of bias assessment were carried out. We assessed the quality of evidence using GRADE.

Main results: The search identified one study of 125 children (72 boys and 53 girls) with calcium-containing idiopathic nephrolithiasis and normal renal morphology following initial treatment with shockwave lithotripsy (SWL). Patients were randomized to oral potassium citrate 1 mEq/kg per day for 12 months versus no specific medication or preventive measure with results reported for a total of 96 patients (48 per group). This included children who were stone-free (n = 52) or had residual stone fragments (n = 44) following SWL. Primary outcomes:Medical therapy may lower rates of stone recurrence with a risk ratio (RR) of 0.19 (95% confidence interval (CI) 0.06 to 0.60; low quality evidence). This corresponds to 270 fewer stone recurrences per 1000 (133 fewer to 313 fewer) children. We downgraded the quality of evidence by two levels for very serious study limitations related to unclear allocation concealment (selection bias) and a high risk of performance, detection and attrition bias. While the data for adverse events were incomplete, they reported that six of 48 (12.5%) children receiving potassium citrate left the trial because of adverse effects. This corresponds to a RR of 13.0 (95% CI 0.75 to 224.53; very low quality evidence); an absolute effect size estimate could not be generated. We downgraded the quality of evidence for study limitations and imprecision.We found no information on retreatment rates.

Secondary outcomes: We found no evidence on serum electrolytes, 24-hour urine collection parameters or time to new stone formation.We were unable to perform any preplanned secondary analyses.

Authors' conclusions: Oral potassium citrate supplementation may reduce recurrent calcium urinary stone formation in children following SWL; however, our confidence in this finding is limited. A substantial number of children stopped the medication due to adverse events. There is no trial evidence on retreatment rates. There is a critical need for additional well-designed trials in children with nephrolithiasis.

PubMed Disclaimer

Conflict of interest statement

AK: none known.

GG: none known.

HM: none known.

LB none known.

Figures

1
1
Risk of bias summary: review authors' judgments about each risk of bias item for each included study (single study).
2
2
Study flow diagram.
3
3
Risk of bias graph: review authors' judgments about each risk of bias item presented as percentages across all included studies (single study).
1.1
1.1. Analysis
Comparison 1 Potassium citrate versus no treatment, Outcome 1 Stone recurrence and regrowth.
1.2
1.2. Analysis
Comparison 1 Potassium citrate versus no treatment, Outcome 2 Adverse events.
See this image and copyright information in PMC

Update of

  • doi: 10.1002/14651858.CD011252

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

References to studies included in this review

Sarica 2006 {published data only}
    1. Sarica K, Erturhan S, Yurtseven C, Yagci F. Effect of potassium citrate therapy on stone recurrence and regrowth after extracorporeal shockwave lithotripsy in children. Journal of Endourology / Endourological Society 2006;20(11):875‐9. - PubMed

References to studies excluded from this review

Choi 2011 {published data only}
    1. Choi JN, Lee JS, Shin JI. Low‐dose thiazide diuretics in children with idiopathic renal hypercalciuria. Acta Paediatrica 2011;100(8):71‐4. - PubMed
Gheissari 2012 {published data only}
    1. Gheissari A, Ziaee A, Farhang F, Farhang F, Talaei Z, Merrikhi A, et al. Evaluating the effectiveness of adding magnesium chloride to conventional protocol of citrate alkali therapy in children with urolithiasis. International Journal of Preventive Medicine 2012;3(11):791‐7. - PMC - PubMed
IRCT2014041217234N1 {unpublished data only}
    1. IRCT2014041217234N1. Comparing effectiveness of combination of magnesium oxide and potassium citrate with potassium citrate in children with urolithiasis. www.irct.ir/searchresult.php?keyword=&id=17234&number=1&prt=... Date first received: 22 December 2014.
Naseri 2011 {published data only}
    1. Naseri M, Sadeghi R. Role of high‐dose hydrochlorothiazide in idiopathic hypercalciuric urolithiasis of childhood. Iranian Journal of Kidney Diseases 2011;5(3):162‐8. - PubMed
NCT00120731 {unpublished data only}
    1. NCT00120731. Effects of potassium citrate in urine of children with elevated calcium in urine and kidney stones. clinicaltrials.gov/ct2/show/study/NCT00120731 Date first received: 19 July 2005.
NCT02289755 {unpublished data only}
    1. NCT02289755. Evaluating ALLN‐177 for reducing urinary oxalate excretion in calcium oxalate kidney stone formers with hyperoxaluria. clinicaltrials.gov/ct2/show/study/NCT02289755 Date first received: 13 November 2014.
Ogûz 2013 {published data only}
    1. Ogûz U, Unsal A. The efficacy of medical prophylaxis in children with calcium oxalate urolithiasis after percutaneous nephrolithotomy. Journal of Endourology / Endourological Society 2013;27(1):92‐5. - PubMed
Tekin 2002 {published data only}
    1. Tekin A, Tekgul S, Atsu N, Bakkaloglu M, Kendi S. Oral potassium citrate treatment for idiopathic hypocitruria in children with calcium urolithiasis. Journal of Urology 2002;168(6):2572‐4. - PubMed
Yousefichaijan 2015 {published data only}
    1. Yousefichaijan P, Cyrus A, Dorreh F, Rafeie M, Sharafkhah M, Frohar F, et al. Oral zinc sulfate as adjuvant treatment in children with nephrolithiasis: a randomized, double‐blind, placebo‐controlled clinical trial. Iranian Journal of Pediatrics 2015;25(6):e1445. - PMC - PubMed

Additional references

Arrabal‐Polo 2013
    1. Arrabal‐Polo MA, Arrabal‐Martin M, Arias‐Santiago S, Garrido‐Gomez J, Poyatos‐Andujar A, Zuluaga‐Gomez A. Importance of citrate and the calcium: citrate ratio in patients with calcium renal lithiasis and severe lithogenesis. BJU International 2013;111(4):622‐7. [MEDLINE: ] - PubMed
Borghi 1996
    1. Borghi L, Meschi T, Amato F, Briganti A, Novarini A, Giannini A. Urinary volume, water and recurrences in idiopathic calcium nephrolithiasis: a 5‐year randomized prospective study. Journal of Urology 1996;155(3):839‐43. [MEDLINE: ] - PubMed
Bush 2010
    1. Bush NC, Xu L, Brown BJ, Holzer MS, Gingrich B, Schuler B, et al. Hospitalizations for pediatric stone disease in United States, 2002‐2007. Journal of Urology 2010;183(3):1151‐6. - PubMed
Dussol 2008
    1. Dussol B, Iovanna C, Rotily M, Morange S, Leonetti F, Dupuy P, et al. A randomized trial of low‐animal‐protein or high‐fiber diets for secondary prevention of calcium nephrolithiasis. Nephron Clinical Practice 2008;110(3):c185‐94. [PUBMED: 18957869] - PubMed
Dwyer 2012
    1. Dwyer ME, Krambeck AE, Bergstralh EJ, Milliner DS, Lieske JC, Rule AD. Temporal trends in incidence of kidney stones among children: a 25‐year population based study. Journal of Urology 2012;188(1):247‐52. [MEDLINE: ] - PMC - PubMed
EndNote [Computer program]
    1. Clarivate Analytics. EndNote. Version 7.6. Clarivate Analytics, 2016.
Escribano 2009
    1. Escribano J, Balaguer A, Pagone F, Feliu A, Roque I, Figuls M. Pharmacological interventions for preventing complications in idiopathic hypercalciuria. Cochrane Database of Systematic Reviews 2009, Issue 1. [DOI: 10.1002/14651858.CD004754.pub2] - DOI - PMC - PubMed
Escribano 2014
    1. Escribano J, Balaguer A, Roque M, Figuls I, Feliu A, Ferre N. Dietary interventions for preventing complications in idiopathic hypercalciuria. Cochrane Database of Systematic Reviews 2014, Issue 2. [DOI: 10.1002/14651858.CD006022.pub4] - DOI - PMC - PubMed
Fink 2013
    1. Fink HA, Wilt TJ, Eidman KE, Garimella PS, MacDonald R, Rutks IR, et al. Medical management to prevent recurrent nephrolithiasis in adults: a systematic review for an American College of Physicians Clinical Guideline. Annals of Internal Medicine 2013;158(7):535‐43. [MEDLINE: ] - PubMed
Golder 2011
    1. Golder S, Loke YK, Bland M. Meta‐analyses of adverse effects data derived from randomised controlled trials as compared to observational studies: methodological overview. PLoS Medicine 2011;8(5):e1001026. - PMC - PubMed
GRADEpro GDT [Computer program]
    1. GRADE Working Group, McMaster University. GRADEpro GDT. Version accessed 17 February 2017. Hamilton (ON): GRADE Working Group, McMaster University, 2015.
Grimsby 2014
    1. Grimsby G, Mayo H, Jacobs MA, Baker LA. Medical and dietary interventions for preventing recurrent urinary stones in children. Cochrane Database of Systematic Reviews 2014, Issue 8. [DOI: 10.1002/14651858.CD011252] - DOI - PMC - PubMed
Guyatt 2008
    1. Guyatt GH, Oxman AD, Vist GE, Kunz R, Falck‐Ytter Y, Schünemann HJ, et al. GRADE: what is "quality of evidence" and why is it important to clinicians?. BMJ (Clinical Research Ed.) 2008;336(7651):995‐8. [DOI: 10.1136/bmj.39490.551019.BE] - DOI - PMC - PubMed
Guyatt 2011
    1. Guyatt G, Oxman AD, Akl EA, Kunz R, Vist G, Brozek J, et al. GRADE guidelines: 1. Introduction ‐ GRADE evidence profiles and summary of findings tables. Journal of Clinical Epidemiology 2011;64(4):383‐94. [DOI: 10.1016/j.jclinepi.2010.04.026] - DOI - PubMed
Heilberg 2013
    1. Heilberg IP, Goldfarb DS. Optimum nutrition for kidney stone disease. Advances in Chronic Kidney Disease 2013;20(2):165‐74. [MEDLINE: ] - PubMed
Higgins 2003
    1. Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta‐analyses. BMJ 2003;327(7414):557‐60. [MEDLINE: ] - PMC - PubMed
Higgins 2011a
    1. Higgins JP, Green S, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from handbook.cochrane.org.
Higgins 2011b
    1. Higgins JPT, Altman DG, Sterne JAC, editor(s). Chapter 8: Assessing risk of bias in included studies. Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from handbook.cochrane.org.
Higgins 2011c
    1. Higgins JPT, Deeks JJ, Altman DG, editor(s). Chapter 16: Special topics in statistics. In: Higgins JPT, Green S, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from handbook.cochrane.org.
Kairam 2013
    1. Kairam N, Allegra JR, Eskin B. Rise in emergency department visits of pediatric patients for renal colic from 1999 to 2008. Pediatric Emergency Care 2013;29(4):462‐4. [MEDLINE: ] - PubMed
Kocvara 1999
    1. Kocvara R, Plasgura P, Petrik A, Louzensky G, Bartonickova K, Dvoracek J. A prospective study of nonmedical prophylaxis after a first kidney stone. BJU International 1999;84(4):393‐8. [MEDLINE: ] - PubMed
Liberati 2009
    1. Liberati A, Altman D, Tetzlaff J, Mulrow C, Gøtzsche P, Ioannidis J, et al. The PRISMA statement for reporting systematic reviews and meta‐analyses of studies that evaluate health care interventions: explanation and elaboration. PLoS Medicine 2009;6(7):e1000100. - PMC - PubMed
Malek 1975
    1. Malek RS, Kelalis PP. Pediatric nephrolithiasis. Journal of Urology 1975;113(4):545‐51. [MEDLINE: ] - PubMed
Milliner 1993
    1. Milliner DS, Murphy ME. Urolithiasis in pediatric patients. Mayo Clinic Proceedings 1993;68(3):241‐8. [MEDLINE: ] - PubMed
Nimkin 1992
    1. Nimkin K, Lebowitz RL, Share JC, Teele RL. Urolithiasis in a children's hospital: 1985‐1990. Urologic Radiology 1992;14(3):139‐43. [MEDLINE: ] - PubMed
Pearle 2005
    1. Pearle MS, Calhoun EA, Curhan GC, Urologic Diseases of America Project. Urologic diseases in America project: urolithiasis. Journal of Urology 2005;173(3):848‐57. [MEDLINE: ] - PubMed
Pietrow 2002
    1. Pietrow PK, Pope JC 4th, Adams MC, Shyr Y, Brock JW 3rd. Clinical outcome of pediatric stone disease. Journal of Urology 2002;167(2 Pt 1):670‐3. [MEDLINE: ] - PubMed
RevMan 2014 [Computer program]
    1. The Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager 5 (RevMan 5). Version 5.3. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2014.
Rule 2014
    1. Rule AD, Lieske JC, Li X, Melton LJ, Krambeck AE, Bergstralh EJ. The ROKS nomogram for predicting a second symptomatic stone episode. Journal of the American Society of Nephrology : JASN 2014;25(12):2878‐86. - PMC - PubMed
Saxena 2010
    1. Saxena A, Sharma RK. Nutritional aspect of nephrolithiasis. Indian Journal of Urology 2010;26(4):523‐30. [MEDLINE: ] - PMC - PubMed
Schünemann 2011
    1. Schünemann HJ, Oxman AD, Higgins JPT, Vist GE, Glasziou P, Guyatt GH. Chapter 11: Presenting results and 'Summary of findings' tables. In: Higgins JPT, Green S, editor(s), Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from handbook.cochrane.org.
Seltzer 1996
    1. Seltzer MA, Low RK, McDonald M, Shami GS, Stoller ML. Dietary manipulation with lemonade to treat hypocitraturic calcium nephrolithiasis. Journal of Urology 1996;156(3):907‐9. [MEDLINE: ] - PubMed
Tasian 2017
    1. Tasian GE, Kabarriti AE, Kalmus A, Furth SL. Kidney stone recurrence among children and adolescents. Journal of Urology 2017;197(1):246‐52. - PMC - PubMed
Trinchieri 1996
    1. Trinchieri A. Epidemiology of urolithiasis. Archivio Italiano di Urologia, Andrologia 1996;68(4):203‐49. [MEDLINE: ] - PubMed
Troup 1972
    1. Troup CW, Lawnicki CC, Bourne RB, Hodgson NB. Renal calculus in children. Journal of Urology 1972;107(2):306‐7. [MEDLINE: ] - PubMed
VanDervoort 2007
    1. VanDervoort K, Wiesen J, Frank R, Vento S, Crosby V, Chandra M, et al. Urolithiasis in pediatric patients: a single center study of incidence, clinical presentation and outcome. Journal of Urology 2007;177(6):2300‐5. [MEDLINE: ] - PubMed
Walther 1980
    1. Walther PC, Lamm D, Kaplan GW. Pediatric urolithiases: a ten‐year review. Pediatrics 1980;65(6):1068‐72. [MEDLINE: ] - PubMed
Wells 2012
    1. Wells GA, Shea B, O'Connell D, Peterson J, Welch V, Losos M, et al. The Newcastle‐Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta‐analyses. www.ohri.ca/programs/clinical_epidemiology/oxford.asp (accessed 20 May 2014).

Publication types

LinkOut - more resources